Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential Therapy
Status:
Recruiting
Trial end date:
2025-02-28
Target enrollment:
Participant gender:
Summary
This study aims to compare the efficacy of the current standard first-line anti-helicobacter
pylori regimen, extended proton pump inhibitor-based sequential therapy, with that of
vonoprazan-based triple therapy, through a randomized controlled trial.